BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35331666)

  • 21. Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes.
    Olarte A; Cambeiro M; Moreno-Jiménez M; Arbea L; Pérez-Gracia JL; Gil-Bazo I; Pascual I; Aristu J; Martínez-Monge R
    Brachytherapy; 2016; 15(2):127-35. PubMed ID: 26832677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-Dose Focal Salvage High Dose Rate Brachytherapy for Locally Recurrent Prostate Cancer.
    Chitmanee P; Tsang Y; Tharmalingam H; Hamada M; Alonzi R; Ostler P; Hughes R; Lowe G; Hoskin P
    Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):259-265. PubMed ID: 31708350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of salvage high dose-rate brachytherapy with or without pelvic external beam radiotherapy in patients with palpable local recurrence of prostate cancer after radical prostatectomy.
    Ni L; Chen K; Phuong C; Sabbagh AR; Wong AC; Mohamad O; Hsu IC
    Brachytherapy; 2023; 22(3):304-309. PubMed ID: 36623988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3D interstitial HDR brachytherapy combined with 3D external beam radiotherapy and androgen deprivation for prostate cancer. Preliminary results.
    Martin T; Hey-Koch S; Strassmann G; Kolotas C; Baltas D; Rogge B; Röddiger S; Vogt HG; Heyd R; Dannenberg T; Kurek R; Tunn U; Zamboglou N
    Strahlenther Onkol; 2000 Aug; 176(8):361-7. PubMed ID: 10987019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of patients with localized and locally advanced prostate cancer undergoing high-dose-rate brachytherapy with external-beam radiotherapy at our institute.
    Makino T; Mizokami A; Namiki M
    Anticancer Res; 2015 Mar; 35(3):1723-8. PubMed ID: 25750334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity.
    Henríquez I; Sancho G; Hervás A; Guix B; Pera J; Gutierrez C; Abuchaibe O; Martínez-Monge R; Tormo A; Polo A
    Radiat Oncol; 2014 Apr; 9():102. PubMed ID: 24885287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center.
    Leroy T; Lacornerie T; Bogart E; Nickers P; Lartigau E; Pasquier D
    Radiat Oncol; 2017 Jun; 12(1):95. PubMed ID: 28599663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence characteristics after focal salvage HDR brachytherapy in prostate cancer.
    Rasing MJA; Peters M; van Son M; Moerland MA; Eppinga W; van de Pol SMG; Noteboom J; Lagendijk J; van der Voort van Zyp JRN
    Radiother Oncol; 2023 Mar; 180():109495. PubMed ID: 36708924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of a protocol-based ultrasound-guided salvage brachytherapy as re-irradiation for local recurrent prostate cancer.
    Schönle N; Strnad V; Lotter M; Kreppner S; Fietkau R
    Radiother Oncol; 2020 Sep; 150():201-205. PubMed ID: 32593646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study.
    Makino T; Sakurai T; Takamatsu S; Iwamoto H; Yaegashi H; Iijima M; Kawaguchi S; Nohara T; Shigehara K; Izumi K; Kadono Y; Mizokami A
    Int J Clin Oncol; 2021 Dec; 26(12):2310-2317. PubMed ID: 34494172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome.
    Jiang P; van der Horst C; Kimmig B; Zinsser F; Poppe B; Luetzen U; Juenemann KP; Dunst J; Siebert FA
    Brachytherapy; 2017; 16(1):186-192. PubMed ID: 28341011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after primary radiotherapy failure.
    Wojcieszek P; Szlag M; Głowacki G; Cholewka A; Gawkowska-Suwińska M; Kellas-Ślęczka S; Białas B; Fijałkowski M
    Radiother Oncol; 2016 Jun; 119(3):405-10. PubMed ID: 27165612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protocol-based image-guided salvage brachytherapy. Early results in patients with local failure of prostate cancer after radiation therapy.
    Lahmer G; Lotter M; Kreppner S; Fietkau R; Strnad V
    Strahlenther Onkol; 2013 Aug; 189(8):668-74. PubMed ID: 23824103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer.
    Maenhout M; Peters M; van Vulpen M; Moerland MA; Meijer RP; van den Bosch MAAJ; Nguyen PL; Frank SJ; van der Voort van Zyp JRN
    Technol Cancer Res Treat; 2017 Dec; 16(6):1194-1201. PubMed ID: 29333958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity.
    Rose JN; Crook JM; Pickles T; Keyes M; Morris WJ
    Brachytherapy; 2015; 14(3):342-9. PubMed ID: 25727178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes.
    Lewin R; Amit U; Laufer M; Berger R; Dotan Z; Domachevsky L; Davidson T; Portnoy O; Tsvang L; Ben-Ayun M; Weiss I; Symon Z
    Radiat Oncol; 2021 Jun; 16(1):114. PubMed ID: 34162398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results.
    Jo Y; Fujii T; Hara R; Yokoyama T; Miyaji Y; Yoden E; Hiratsuka J; Nagai A
    BJU Int; 2012 Mar; 109(6):835-9. PubMed ID: 21933327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approach.
    Gomez-Iturriaga A; Zaragoza L; Valverde I; Perez Azorin F; Santos-Zorrozua B; Guerrero JA; Couñago F; Cacicedo J; Marban M; Santana S; Mascarell C; Novo E; Fernandez R; Garcia-Olaverri J; Urresola A; Ezquerro A; Büchser D
    Radiother Oncol; 2024 Jan; 190():110024. PubMed ID: 37995851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer.
    Hsu CC; Hsu H; Pickett B; Crehange G; Hsu IC; Dea R; Weinberg V; Gottschalk AR; Kurhanewicz J; Shinohara K; Roach M
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):370-7. PubMed ID: 22672747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer.
    Martin T; Röddiger S; Kurek R; Dannenberg T; Eckart O; Kolotas C; Heyd R; Rogge B; Baltas D; Tunn U; Zamboglou N
    Radiother Oncol; 2004 Apr; 71(1):35-41. PubMed ID: 15066294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.